| 1 |
32552305 | Third-line sunitinib treatment in a VHL-mutated metastatic intrahepatic cholangiocarcinoma: a case report and literature review. | 2020 Sep 1 |
5 |
| 2 |
30705246 | Hypoxia-Associated Factor (HAF) Mediates Neurofibromin Ubiquitination and Degradation Leading to Ras-ERK Pathway Activation in Hypoxia. | 2019 May |
1 |
| 3 |
31268155 | Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment. | 2019 Aug |
2 |
| 4 |
27485825 | Synergy between von Hippel-Lindau and P53 contributes to chemosensitivity of clear cell renal cell carcinoma. | 2016 Sep |
3 |
| 5 |
27974690 | Benefit of Sunitinib in the treatment of pulmonary primitive neuroectodermal tumors: a case report and literature review. | 2016 Dec 27 |
2 |
| 6 |
24783204 | RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma. | 2014 |
1 |
| 7 |
20368728 | Alterations in VHL as potential biomarkers in renal-cell carcinoma. | 2010 May |
1 |
| 8 |
17189392 | Targeting von Hippel-Lindau pathway in renal cell carcinoma. | 2006 Dec 15 |
1 |